Concepedia

Susana Liu

SL

19

Publications

1.9K

Citations

16

H-Index

1988

Active since

Affiliations

Merck Canada Inc. (Canada)(Current)

Stanford University

Stanford Medicine

Merck & Co., Inc., Rahway, NJ, USA (United States)

Susana Liu is an author at Merck Canada Inc. (Canada) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryPharmacotherapyDrug DevelopmentMolecular PharmacologyAnesthesiology

Publications per year

1988–2011

19

Publications

19

Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate

Gregory Huyer, Susana Liu, John A. Kelly et al. · Journal of Biological Chemistry · 1997 · 825 citations · Full text

Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis

Annette Robichaud, Panagiota B. Stamatiou, S.-L. Catherine Jin et al. · Journal of Clinical Investigation · 2002 · 266 citations · Full text

Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis

Annette Robichaud, Panagiota B. Stamatiou, S.-L. Catherine Jin et al. · Journal of Clinical Investigation · 2002 · 258 citations

Type 4, Anesthetic Mechanism, Rolipram-sensitive Pde Activity +24

Conformational Difference between PDE4 Apoenzyme and Holoenzyme

France Laliberté, Yongxing Han, Arvind Govindarajan et al. · Biochemistry · 2000 · 88 citations

Protein Chemistry, Biochemistry, Type 4 +14

Preferential inhibition of human phosphodiesterase 4 by ibudilast

Zheng Huang, Susana Liu, Lei Zhang et al. · Life Sciences · 2005 · 60 citations

Molecular Pharmacology, Autoimmune Disease, Preferential Inhibition +5

Rows per page

1–5 of 19